Press "Enter" to skip to content

Antibody Production Market Outlook 2019 | Shows Industry Overview, Size, Share, Remarkable Growth Factors, Types, and Applications Forecast to 2024

Antibody

The “Antibody Production Market” research report 2019-2024 delivers comprehensive information and valuable insights about the Antibody Production industry. The information available in the Antibody Production market report is not only based on the facts but also on the case studies, which analysts have included to convey appropriate information to the clients in a well-versed manner. Antibody Production market report includes valuable information to assist new entrants, as well as established players, to understand the prevailing trends in the market.

Some Companies Are Covered in the Antibody Production Market:

  • Applikon Biotechnology Inc.
  • Cellab GmbH
  • Danaher Corporation
  • Eppendorf AG
  • GE Healthcare
  • Genetix Biotech Asia Pvt Ltd
  • Merck KGaA
  • Sartorius AG
  • Solaris Biotech
  • Thermo Fisher Scientific Inc.

    Get a Sample Copy of the Report – https://www.industryresearch.co/enquiry/request-sample/14245672

    Market Overview:

  • The major factors for the growth of the antibody production market include the rising adoption of targeted immunotherapy, the increase in the R&D expenditure of pharmaceutical and biotechnology companies, and the rising demand for therapeutic antibodies.
  • Antibodies are used in the treatment of various diseases, such as cancer, rheumatoid arthritis, and other chronic diseases. The targeted therapy is attaining importance due to its specificity toward cancer cells while sparing the toxicity to off-target cells. As there is a rising prevalence of cancer, targeted therapies are getting more attention. For instance, according to the estimates of the American Cancer Society, in 2018, there were 1,735,350 new cancer cases diagnosed and 609,640 deaths, due to cancer, in the United States. Some of the examples of monoclonal antibodies used in targeted therapies are bevacizumab, cetuximab, and ipilimumab.
  • The rising adoption of targeted therapies is expected to propel the overall growth of the antibody production market over the forecast period. Furthermore, there is an increase in R&D activities by most of the pharmaceutical and biotechnology companies, in order to develop advanced biologics. The success rates and blockbuster sales of biologics have also made large pharmaceutical companies shift their presence to biopharma. Over the past two decades, the chimerization and humanization of mAbs (monoclonal antibodies) have led to the approval of several for the treatment of autoimmune diseases, cancer, and transplant rejection.
  • However, the costs of antibody production and stringent government regulations are expected to impede the growth of the market.

    Scope of the Report:

  • As per the , antibody production refers to the process of creating a specific antibody. In a broad sense, it consists of various methods, such as upstream, downstream, and filtration. The process involves the preparation of antigen samples, which are injected to the laboratory or farm animals to evoke high expression levels of antigen-specific antibodies in the serum, which are then recovered from the animal. The market is expected to witness significant growth, owing to the increase in R&D expenditure of pharmaceutical and biotechnology companies.

    Reasons for Buying Antibody Production Market Report:

    • This report provides pin-point analysis for changing competitive dynamics
    • It provides a forward looking perspective on different factors driving or restraining market growth
    • It provides a five-year forecast assessed on the basis of how the market is predicted to grow
    • It helps in understanding the key product segments and their future
    • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
    • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

    For More Information or Query or Customization Before Buying, Visit at – https://www.industryresearch.co/enquiry/pre-order-enquiry/14245672

    Key Market Trends:

    The Monoclonal Antibodies Segment under the Antibody Type Accounted for the Largest Share in the Global Market

    Monoclonal antibodies have large applications in the field of diagnostics, therapeutics, and targeted drug delivery systems, not only for infectious diseases caused by bacteria, viruses, and protozoa, but also for cancer, metabolic, and hormonal disorders. This segment is expected to account for the largest market share during the forecast period, owing to the rising investment in monoclonal antibody research and an increase in antibody-based product launches. Furthermore, there is a growing collaboration between pharma companies to develop advanced monoclonal antibodies. For instance, recently, in September 2018, Integral Molecular and Merus NV announced that they have entered into a collaboration on multiple undisclosed targets, as Integral Molecular is one of the leaders in membrane protein antibody discovery. The partnership is expected to increase the R&D capabilities of Merus NV.

    The polyclonal antibody segment is expected to be the fastest-growing market, owing to benefits, such as ease of production, low price, and diagnosis of diseases with high proficiency.

    North America Accounted for the Largest Share in the Global Market

    North America is found to hold a significant share in the antibody production market and is expected to show a similar trend over the forecast period, without substantial fluctuations. The presence of favorable healthcare infrastructure and the rising prevalence of various chronic diseases are the major factors driving the growth of the market. Furthermore, there is a rise in the approval of monoclonal antibodies for the treatment of cancer and various types of diseases, which is one of the major factors contributing to the high growth of the market in North America. For instance, in May 2018, Novartis announced that the US FDA approved Kymriah (tisagenlecleucel) suspension for the treatment of adult patients with relapsed or refractory large B-cell lymphoma.

    Antibody Production Market Report Provides Comprehensive Analysis of:

    • Functional market industry outline
    • Up and downstream industry examination
    • Channels and propositions believability
    • Market challenge by key players
    • Enhancement suggestions examination

    Purchase this Report (Price 4250 USD for single user license) – https://www.industryresearch.co/purchase/14245672

    Report Highlights:

    • Market Dynamics – Drivers, Restraints, and Opportunities
    • Market Segmentation – Types, Applications, Regions, and Technology
    • Market Trends
    • Competitive Landscape
    • SWOT Analysis and Porter’s Five Forces Analysis

    Detailed TOC of Antibody Production Market Report 2019-2024:

    1 INTRODUCTION
    1.1 Study Deliverables
    1.2 Study Assumptions
    1.3 Scope of the Study

    2 RESEARCH METHODOLOGY

    3 EXECUTIVE SUMMARY

    4 MARKET DYNAMICS
    4.1 Market Overview
    4.2 Market Drivers
    4.2.1 Rising Adoption of Targeted Immunotherapy
    4.2.2 Increase in the R&D Expenditure of Pharmaceutical and Biotechnology Companies
    4.2.3 Rising Demand for Therapeutic Antibodies
    4.3 Market Restraints
    4.3.1 High Costs Involved in the Antibody Production
    4.3.2 Stringent Government Regulations
    4.4 Porter’s Five Forces Analysis
    4.4.1 Threat of New Entrants
    4.4.2 Bargaining Power of Buyers/Consumers
    4.4.3 Bargaining Power of Suppliers
    4.4.4 Threat of Substitute Products
    4.4.5 Intensity of Competitive Rivalry

    5 MARKET SEGMENTATION
    5.1 Antibody Type
    5.1.1 Monoclonal Antibodies
    5.1.2 Polyclonal Antibodies
    5.1.3 Other Antibody Types
    5.2 Process
    5.2.1 Upstream Processing
    5.2.1.1 Bioreactors
    5.2.1.2 Consumables
    5.2.2 Downstream Processing
    5.2.2.1 Chromatography Systems
    5.2.2.2 Chromatography Resins
    5.2.3 Filtration
    5.3 End User
    5.3.1 Pharmaceutical and Biotechnology Companies
    5.3.2 Research Laboratories
    5.3.3 Other End Users
    5.4 Geography
    5.4.1 North America
    5.4.1.1 US
    5.4.1.2 Canada
    5.4.1.3 Mexico
    5.4.2 Europe
    5.4.2.1 Germany
    5.4.2.2 UK
    5.4.2.3 France
    5.4.2.4 Italy
    5.4.2.5 Spain
    5.4.2.6 Rest of Europe
    5.4.3 Asia-Pacific
    5.4.3.1 China
    5.4.3.2 Japan
    5.4.3.3 India
    5.4.3.4 Australia
    5.4.3.5 South Korea
    5.4.3.6 Rest of Asia-Pacific
    5.4.4 Middle East & Africa
    5.4.4.1 GCC
    5.4.4.2 South Africa
    5.4.4.3 Rest of Middle East & Africa
    5.4.5 South America
    5.4.5.1 Brazil
    5.4.5.2 Argentina
    5.4.5.3 Rest of South America

    6 COMPETITIVE LANDSCAPE
    6.1 Company Profiles
    6.1.1 Applikon Biotechnology Inc.
    6.1.2 Cellab GmbH
    6.1.3 Danaher Corporation
    6.1.4 Eppendorf AG
    6.1.5 GE Healthcare
    6.1.6 Genetix Biotech Asia Pvt Ltd
    6.1.7 Merck KGaA
    6.1.8 Sartorius AG
    6.1.9 Solaris Biotech
    6.1.10 Thermo Fisher Scientific Inc.

    7 MARKET OPPORTUNITIES AND FUTURE TRENDS

     

    Contact Us:

    Name: Ajay More

    Phone: US +14242530807/ UK +44 20 3239 8187

    Email: [email protected]

    Our Other Reports:

    Surgical Robots for the Spine Market 2019 Industry Size, Trends Evaluation, Global Growth, Recent Developments and Latest Technology, Future Forecast Research Report 2024

    Photographic Paper Market 2019: Highlights Recent Trends, Market Growth, Top Manufacturers Analysis, Business Opportunities and Demand

    Aviation Fuel Market 2019 – Global Industry Size by Leading Manufacturers, Growth Rate, Demand Status, Professional Study Forecast to 2026

    Global Synthetic Ropes Market 2019 – Industry Analysis by Top Key Players, Key Countries, Market Size & Share, Growth Rate Forecast to 2023